Axcan Pharma Continues its Solid Growth Trend, Closing Fiscal 2007 With Record Annual Revenue of $348.9 Million, a 19.4% Increase Over Fiscal 2006

MONT-SAINT-HILAIRE, QUEBEC--(Marketwire - November 29, 2007) - Axcan Pharma Inc. (TSX: AXP)(NASDAQ: AXCA) today announced fourth quarter and year-end financial results. Axcan's fiscal year 2007 was very successful with strong operating results and cash flows. All amounts are in U.S. dollars.